Anti-Epstein-Barr Virus, EA-D (EBV-1822)

Anti-Epstein-Barr Virus, EA-D (EBV-1822)

Product No.: E159

- -
- -
Clone
EBV-1822
Target
Early antigen-diffuse (EA-D)
Formats AvailableView All
Product Type
Hybridoma Monoclonal Antibody
Alternate Names
EBV, Mono, Infectious Mononucleosis
Isotype
Mouse IgG2
Applications
IF
,
IHC
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactivity Species
Epstein-Barr Virus
Host Species
Mouse
Product Concentration
≥1.0 mg/ml
Purity
≥90%
Formulation
Formulated in 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1% sodium azide. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
State of Matter
Liquid
Product Preparation
This monoclonal antibody is purified by protein A chromatography or sequential differential precipitations.
Storage and Handling
This purified antibody is stable when stored at 2-8°C. Do not freeze.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
2-8°C Wet Ice
Applications and Recommended Usage?
Quality Tested by Leinco
IF: 1:10-1:50,
WB,
IHC
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Anti-EBV (Clone EBV-1822) is specific for the Early antigen-diffuse (EA-D) protein.
Background
Epstein-Barr virus (EBV) is an enveloped DNA virus that is a member of the herpes virus family and is also known as Human gammaherpesvirus 4. It is one of the most common human viruses, with most people being infected at some point during their lives. EBV is transmitted through saliva, and infections are most common in childhood and adolescence. While many people who are infected with EBV will not experience any symptoms, others may develop infectious mononucleosis (commonly known as "mono" or the "kissing disease"), a condition characterized by fever, sore throat, swollen lymph nodes, and fatigue. The virus primarily infects B cells and once the initial infection is controlled by the immune system, the virus becomes latent which can lead to a recurrence later in life if the virus is reactivated. EBV has been causally associated with various types of cancer (known collectively as EBV-associated tumors) including Hodgkin’s disease, nasopharyngeal carcinoma, and Burkitt’s lymphoma.

Antigen Details

Antigen
Early antigen-diffuse (EA-D)
Research Area
Infectious Disease
.
Sexually Transmitted Infections
.
Viral
.
IVD Raw Material

References & Citations

IF
IHC
General Western Blot Protocol

Formats Available

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.